C. Schambeck

发表

Selective Screening for the Factor V Leiden Mutation: Is it Advisable prior to the Prescription of Oral Contraceptives?

R. Grossmann, C. Schambeck, S. Schwender, 1997, Thrombosis and Haemostasis.

Familial Clustering of High Factor VIII Levels in Patients With Venous Thromboembolism

B. M. Taleghani, C. Schambeck, I. Haubitz, 2001, Arteriosclerosis, thrombosis, and vascular biology.

Functional Classification of Paediatric Patients with Non-syndromic Delta-Storage Pool Deficiency

H. Schulze, S. Eber, G. Manukjan, 2018, Hämostaseologie.

Diagnose angeborener Störungen der Thrombozytenfunktion

O. Meyer, T. Scholl, C. Geisen, 2014, Hämostaseologie.

Antibodies to platelet factor 4-heparin complex and outcome in hemodialysis patients with diabetes.

C. Wanner, K. Winkler, V. Krane, 2010, Clinical journal of the American Society of Nephrology : CJASN.

Plasma cell proliferation in monoclonal gammopathies: measurement using BU-1 antibody in flow cytometry and microscopy: comparison with serum thymidine kinase.

R. Lamerz, R. Bartl, C. Schambeck, 1995, Journal of clinical pathology.

Molecular defects in the ABCA1 pathway affect platelet function.

G. Schmitz, C. Schambeck, 2005, Pathophysiology of haemostasis and thrombosis.

APC-Resistenz - 10 Jahre danach / APC Resistence - 10 years later

C. Schambeck, 2004 .

Fibrinolysis – new perspectives Fibrinolysis-neue Perspektiven

C. Schambeck, 2005 .

Recent Advances in Molecular Diagnostics of Thrombophilia

C. Schambeck, 2001 .

Editorial: Analysis of Platelet Function and Dysfunction – From Pathobiochemistry to Diagnostics –

U. Walter, C. Schambeck, 2002 .

Methodological and clinical comparison of the ACS prostate-specific antigen assay and the Tandem-E prostate-specific antigen assay in prostate cancer.

H. Pahl, P. Stieber, C. Schambeck, 1995, Urology.

[Screening for thrombophilia].

C. Schambeck, T. Lammers, 2008, Hamostaseologie.

Therapie hereditärer Thrombozytopathien

R. Zotz, U. Scholz, W. Kreuz, 2014, Hämostaseologie.

[Therapy of inherited diseases of platelet function. Interdisciplinary S2K guideline of the Permanent Paediatric Committee of the Society of Thrombosis and Haemostasis Research (GTH e. V.)].

R. Zotz, U. Scholz, W. Kreuz, 2014, Hamostaseologie.

Familiäres Antiphospholipidsyndrom / Familial antiphospholipid syndrome

C. Schambeck, 2008 .

PFA-100®: Globaltest der primären Hämostase?/PFA-100®: Global Test for Primary Haemostasis?

C. Schambeck, 2002 .

Molecular Defects in the ABCA1 Pathway Affect Platelet Function

G. Schmitz, C. Schambeck, 2006, Pathophysiology of Haemostasis and Thrombosis.

High factor VIII levels in venous thromboembolism show linkage to imprinted loci on chromosomes 5 and 11.

K. Strauch, M. Mattheisen, H. Bickeböller, 2005, Blood.

Association of ADAMDEC1 haplotype with high factor VIII levels in venous thromboembolism

M. Spannagl, B. Kulle, B. Luxembourg, 2008, Thrombosis and Haemostasis.

Screening tests for abnormalities of the protein C anticoagulant pathway / Suchteste für Anomalien im antikoagulatorischen Protein C-System

C. Schambeck, 2004 .

Defective Zn2+ homeostasis in mouse and human platelets with α- and δ-storage pool diseases

P. Nurden, H. Hermanns, B. Nieswandt, 2019, Scientific Reports.

Compound-heterozygous mutations in the plasminogen gene predispose to the development of ligneous conjunctivitis.

E. Stiehm, S. Seregard, E. R. Stiehm, 1999, Blood.

Homozygous and Compound-heterozygous Type I Plasminogen Deficiency Is a Common Cause of Ligneous Conjunctivitis

U. Ozcelik, F. Meire, V. Schuster, 2001, Thrombosis and Haemostasis.

High factor VIII (FVIII) levels in venous thromboembolism: role of unbound FVIII

Mario Berger, R. Grossmann, U. Walter, 2004, Thrombosis and Haemostasis.

Transient Alkaline Hyperphosphatasaemia in an Adult: Biochemical Peculiarities

C. Schambeck, A. Kopp, F. Keller, 1997, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

Blutungsneigung: Diagnostische Strategie zur Abklärung einer Thrombozytendysfunktion. Consensus-Papier der DGKL-Arbeitsgruppe “Hämostaseologische Labordiagnostik” / Bleeding Tendency: Strategy for the clarification of platelet dysfunction. Consensus paper of the DGKL Working Group on Laboratory Diag

C. Schambeck, 2004 .

Limit of quantification (functional sensitivity) of the new IMx Tacrolimus II microparticle enzyme immunoassay.

A. Bedel, C. Schambeck, F. Keller, 1998, Clinical chemistry.

Etiology and VTE risk factor distribution in patients with inferior vena cava thrombosis.

M. Schindewolf, R. Grossmann, B. Linnemann, 2009, Thrombosis research.

HYPOTHYREOSE UND KREATINKINASE

K. Badenhoop, C. Schambeck, 1997 .

Genetic risk factors in young adults with ‘cryptogenic’ ischemic cerebrovascular disease

W. Müllges, R. Grossmann, U. Walter, 2002, Blood Coagulation and Fibrinolysis.

Venous Thromboembolism and Associated High Plasma Factor VIII Levels:Linked to Cytomegalovirus Infection?

C. Schambeck, F. Keller, K. Hinney, 2000, Thrombosis and Haemostasis.

Defective Zn2+ homeostasis in mouse and human platelets with α- and δ-storage pool diseases

P. Nurden, H. Hermanns, B. Nieswandt, 2019, Scientific Reports.

Cytomegalovirus infection is associated with venous thromboembolism of immunocompetent adults—a case–control study

E. Seifried, S. Schimanski, B. Luxembourg, 2012, Annals of Hematology.

CBS 844ins68, MTHFR TT677 and EPCR 4031ins23 genotypes in patients with deep-vein thrombosis.

R. Grossmann, U. Walter, C. Schambeck, 2002, Thrombosis research.

Characterization of Myeloma Cells by Means of Labeling Index, Bone Marrow Histology, and Serum /^-Microglobulin

R. Lamerz, R. Bartl, C. Schambeck, 2015 .

Clinical relevance of CYFRA 21-1, TPA-IRMA and TPA-LIA-mat in urinary bladder cancer.

P. Stieber, C. Schambeck, N. Schmeller, 1996, Anticancer research.

Comparison of Cyfra 21–1, Tpa and Tps in Lung Cancer, Urinary Bladder Cancer and Benign Diseases

H. Dienemann, M. Untch, P. Stieber, 1994, The International journal of biological markers.